image
Vicks Action 500 Extra banned
Mumbai, Mar 15 (IBNS) After Corex and Phensedyl it is now Vicks Action 500 Extra as FMCG major Procter and Gamble (P&G) has discontinued manufacture and sale of its popular brand of cold and flu pill with immediate effect after the government banned fixed dose combination drugs.
"The Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination drugs (Paracetamol + Phenylephrine + Caffeine) with immediate effect," Pfizer said in a BSE filing.
"Our product 'Vicks Action 500 Extra' has the same fixed dose combination and gets covered under notification. we have discontinued the manufacture and sale of all SKUs of 'Vicks Action 500 Extra with immediate effect."
On Monday, Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively, after the government banned over 300 fixed dose combinations (FDCs) drugs.
Corex had garnered sales of Rs 176 crore in the nine-month period ended December 31. Pfizer admitted that the government's move will have an adverse impact on it.
Top Headlines
-
News
Sona College of Technology launches Sona ChipIN Centre with latest semiconductor EDA tools
May 16, 2026
-
News
ECI announces third phase of SIR; Himachal, J&K, Ladakh excluded for now
May 14, 2026
-
News
Putin unleashes Satan 2: Russia tests ICBM with 35,000 km range
May 13, 2026
-
News
2 killed, 3 critically injured in multi-storey building fire in Kolkata's Tiljala
May 12, 2026
-
News
Who after Mamata in Bengal? Amit Shah to meet BJP MLA-elects ahead of May 9 oath
May 06, 2026
-
News
Mamata Banerjee refuses to 'resign', calls EC 'villain'
May 05, 2026
-
News
Bengal trends: BJP on course to form government
May 04, 2026
-
News
Bangladesh MP warns of refugee crisis if BJP wins West Bengal polls
May 01, 2026
-
News
Rain, protests, and slogans: TMC-BJP faceoff erupts outside Kolkata's Netaji Indoor Stadium strong room
April 30, 2026
-
News
Bengal polls: Mamata rejects exit poll projections, claims decisive TMC return to power
April 30, 2026
